SEC 13F Intelligence

Consonance Capital Management LP / AUPH

Consonance Capital Management LP’s Aurinia Pharmaceuticals Inc Position

Does Consonance Capital Management LP own Aurinia Pharmaceuticals Inc (AUPH)? Not currently — the last reported position was 4.62M shares worth $75M in Q2 2020; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$75M
Q2 2020
Shares
4.62M
% of Portfolio
+4.50%
Quarters Held
6
position exited

Position History AUPH

Reported value by quarter
Q1 ’19: $27MQ1 ’19Q2 ’19: $28MQ2 ’19Q3 ’19: $14MQ3 ’19Q4 ’19: $134MQ4 ’19Q1 ’20: $100MQ1 ’20Q2 ’20: $75MQ2 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20204.62M$75M+4.50%
Q1 20206.91M$100M+7.47%
Q4 20196.63M$134M+8.19%
Q3 20192.56M$14M+1.35%
Q2 20194.22M$28M+1.97%
Q1 20194.22M$27M+1.73%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of AUPH.